Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Cancers|April 3, 2021
Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast CancerMalina Xiao, Meriem Hasmim, Audrey Lequeux, et al.
Seminars in Cancer Biology|November 29, 2023
Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapyRaefa Abou Khouzam, Bassam Janji, Jerome Thiery, et al.
Oncotarget|February 25, 2016
The multifaceted role of autophagy in tumor evasion from immune surveillanceBassam Janji, Elodie Viry, Etienne Moussay, et al.
Frontiers in Immunology|July 5, 2017
Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell SubsetMathieu Amand, Gilles Iserentant, Aurélie Poli, et al.
Science Advances|June 5, 2020
Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapyMuhammad Zaeem Noman, Santiago Parpal, Kris Van Moer, et al.
Frontiers in Immunology|September 26, 2022
SNAI1-dependent upregulation of CD73 increases extracellular adenosine release to mediate immune suppression in TNBCMeriem Hasmim, Malina Xiao, Kris Van Moer, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2017
Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent mannerTakouhie Mgrditchian, Tsolere Arakelian, Jérôme Paggetti, et al.
Cancer Research|August 15, 2018
Actin Cytoskeleton Remodeling Drives Breast Cancer Cell Escape from Natural Killer-Mediated CytotoxicityAntoun Al Absi, Hannah Wurzer, Coralie Guerin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2013
Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxiaJoanna Baginska, Elodie Viry, Guy Berchem, et al.
Cell Chemical Biology|October 1, 2025
Inter- and intra-tumoral ALDH1 heterogeneity in breast cancer identifies therapeutic opportunities for ALDH1A-specific inhibitorsRaquel Pequerul, Andrada Constantinescu, Bassam Janji, et al.
Pageof 10